ANOUSH COSTANIAN: Open Payments
NPI 1932827391 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,291 in 63 payments from 21 companies in 2025. Trend: 2023 $3,648 · 2024 $1,434 · 2025 $2,291
Food & beverage: $1,496Consulting: $795
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 5 | $853 |
| ABBVIE INC. | 17 | $268 |
| Eisai Inc. | 6 | $247 |
| Alexion Pharmaceuticals, Inc. | 5 | $185 |
| Teva Pharmaceuticals USA, Inc. | 3 | $160 |
| TG Therapeutics, Inc. | 1 | $123 |
| Axsome Therapeutics, Inc. | 4 | $59 |
| JAZZ PHARMACEUTICALS INC. | 3 | $49 |
| UCB, Inc. | 2 | $39 |
| Merz Pharmaceuticals, LLC | 2 | $37 |
Products named: VYEPTI, Leqembi, UBRELVY, ULTOMIRIS, AUSTEDO XR, BRIUMVI, Symbravo, XYWAV.
Industry payments across NJ — which companies pay providers there.
